Detalhe da pesquisa
1.
A pan-cancer analysis of the microbiome in metastatic cancer.
Cell
; 187(9): 2324-2335.e19, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599211
2.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med
; 22(1): 9, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191387
3.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Breast Cancer Res
; 25(1): 53, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161532
4.
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Breast Cancer Res
; 25(1): 117, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794508
5.
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Breast Cancer Res
; 19(1): 119, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116004
6.
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
PLoS Genet
; 10(4): e1004285, 2014 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24743323
7.
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
Am J Hum Genet
; 92(4): 489-503, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23540573
8.
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
Carcinogenesis
; 36(2): 256-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586992
9.
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Res
; 17: 58, 2015 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897948
10.
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.
Int J Cancer
; 132(9): 2044-55, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23034890
11.
Immune landscape of breast tumors with low and intermediate estrogen receptor expression.
NPJ Breast Cancer
; 9(1): 39, 2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179445
12.
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.
JCO Precis Oncol
; 7: e2200670, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738542
13.
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.
J Exp Med
; 220(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920329
14.
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Genome Med
; 15(1): 7, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703164
15.
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Nat Genet
; 55(9): 1435-1439, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592023
16.
11q13 is a susceptibility locus for hormone receptor positive breast cancer.
Hum Mutat
; 33(7): 1123-32, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22461340
17.
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
Cancers (Basel)
; 14(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884425
18.
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
J Clin Oncol
; 40(21): 2361-2374, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353548
19.
Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression.
NPJ Breast Cancer
; 7(1): 118, 2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508103
20.
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
PLoS One
; 14(5): e0216864, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125352